Non-invasive brain stimulation for treatment of schizophrenic psychoses

Der Nervenarzt
A HasanC Plewnia

Abstract

Despite many different available pharmacological and psychosocial treatment options, an optimal control of symptoms is only partly possible for most schizophrenia patients. Especially, persistent auditory hallucinations, negative symptoms and cognitive impairment are difficult to treat symptoms. Several non-invasive brain stimulation techniques are increasingly being considered as new therapeutic add on options for the management of schizophrenia, targeting these symptom domains. The technique which has been available for the longest time and that is best established in clinical care is electroconvulsive therapy (ECT). New stimulation techniques, such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) allow a more pathophysiological-based approach. This review article introduces various non-invasive brain stimulation techniques and discusses recent treatment studies on schizophrenia. In total, the novel brain stimulation techniques discussed here can be considered relevant add on therapeutic approaches for schizophrenia. In this context, the best evidence is available for the application of rTMS for the treatment of negative symptoms and persistent auditory hallucinations; ...Continue Reading

References

Jan 2, 2004·The American Journal of Psychiatry·Dennis S Charney
Nov 9, 2004·Schizophrenia Research·Keith H NuechterleinRobert K Heaton
Jan 25, 2005·Neuron·Ying-Zu HuangJohn C Rothwell
Apr 23, 2005·The Cochrane Database of Systematic Reviews·P Tharyan, C E Adams
Oct 14, 2005·Schizophrenia Bulletin·Philip D HarveyChristopher R Bowie
Apr 28, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Charles B NemeroffStephen K Brannan
Mar 4, 2008·British Journal of Pharmacology·J A PrattB J Morris
Aug 14, 2008·The International Journal of Neuropsychopharmacology·Christian PlewniaDirk Freudenstein
Sep 12, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Wataru SakoRyuji Kaji
Oct 28, 2009·Journal of Neural Transmission·Birgit GuseThomas Wobrock
Dec 4, 2009·Schizophrenia Bulletin·Robert W BuchananUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Jul 1, 2010·Stereotactic and Functional Neurosurgery·Edward F ChangJill L Ostrem
Jul 1, 2008·Brain Stimulation·Ulf ZiemannJohn C Rothwell
Jul 1, 2008·Brain Stimulation·Michael A NitscheAlvaro Pascual-Leone
Nov 3, 2010·The American Journal of Psychiatry·Mark-Christian EberleChristian Plewnia
Aug 16, 2011·Journal of Neurosurgery·Dario J EnglotKurtis I Auguste
Oct 7, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Moacyr A Rosa, Sarah H Lisanby
Dec 6, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·J L R Martin, E Martín-Sánchez
Dec 16, 2011·Trends in Cognitive Sciences·Deanna M Barch, Alan Ceaser
Mar 1, 2012·Schizophrenia Bulletin·Iris E C SommerMark van der Gaag
May 15, 2012·The American Journal of Psychiatry·Jerome BrunelinEmmanuel Poulet
Jun 5, 2012·Cerebral Cortex·Masashi HamadaJohn C Rothwell
Jul 28, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia
Dec 12, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN WFSBP Task force on Treatment Guidelines for Schizophrenia
Sep 10, 2013·Biological Psychiatry·Tristram A LettZafiris J Daskalakis
Dec 10, 2013·Biological Psychiatry·Christina W SlotemaIris E C Sommer
Jul 11, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Stephanie M PerezDaniel J Lodge
Jul 19, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Jean-Pascal LefaucheurLuis Garcia-Larrea
Aug 27, 2014·The American Journal of Psychiatry·Georgios PetridesAlan Mendelowitz
Oct 14, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Wolfgang StrubeAlkomiet Hasan
Oct 17, 2014·JAMA Psychiatry·Bret R RutherfordJeffrey A Lieberman

❮ Previous
Next ❯

Citations

Jul 22, 2016·Der Nervenarzt·M BauerH-U Wittchen
May 17, 2019·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Duraisamy KempurajAsgar Zaheer
Jul 5, 2018·Der Nervenarzt·U Wiesing, A J Fallgatter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.